The first Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) drug, Nevirapine, is approved in the US.
The era of Highly Active Antiretroviral Treatment (HAART) begins, with immediate and dramatic benefits for those with access.
A new type of drug-blocking HIV replication - protease inhibitors - are approved in the USA.
AZT approved for prevention of mother-to-child transmission by USA Federal Drug Administration.
Brazil starts producing a generic version of HIV treatment drug AZT.
The first HIV treatment is approved for use in children.
The first HIV drug – zidovudine (AZT) – is approved for treatment of people living with HIV by the USA Food and Drugs Administration (FDA).
The USA Centres for Disease Control (CDC) issues its first guidance on preventing mother-to-child transmission of HTLV-III/LAV (later known as HIV).
New World Health Organization guidelines recommend beginning antiretroviral treatment immediately after HIV diagnosis.
For the first time, more than half of people needing treatment globally are receiving it.
